Stefanie Rechtsteiner

Boehringer Ingelheim

Stefanie has been working in the pharmaceutical industry for many years, starting in biotech, moving on to marketing/sales, until she specialised in safety writing from 2011 onwards. She has extensive hands-on experience on DSUR, RMP, AddCO, and PBRER writing and currently works as a principal pharmacovigilance writer at Boehringer Ingelheim. Stefanie joined EMWA in 2011.